Neurovascular Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Neurovascular Medical Devices Companies & Size and it is Segmented by Product (Aneurysm Coiling & Embolization Devices, Cerebral Balloon Angioplasty and Stenting Systems, Support Devices, Neurothrombectomy Devices, and Others), Target Disease (Ischemic Strokes, Cerebral Aneurysms, Arteriovenous Malformation, and Fistulas and Other target diseases) and Geography (North America, Europe, Asia-pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above segments.

Neurovascular Devices Market Size

Neurovascular Devices Market Summary
share button
Study Period 2021 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 7.70 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Neurovascular Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Neurovascular Devices Market Analysis

During the period of the forecast, the market for neurovascular devices is expected to register a compound annual growth rate (CAGR) of 7.7%.

COVID-19 had a profound impact on the neurovascular devices market owing to the cancellations of elective procedures, including neurosurgery. For instance, an article published in the BMJ Public Health Emergency Collection Journal in August 2022 stated that out of the total of 680 enrolled patients on the waiting list for scheduled neurosurgical procedures, 470 patients (69.1%) were waiting for surgery due to degenerative spine disease, 86 patients (12.6%) due to functional disorders, 58 patients (8.5%) due to brain or spine tumors, 25 patients (3.7%) due to CSF disorders, and 17 patients (2.5%) due to cerebrovascular disease in Spain. However, the market has been recovering post-pandemic since the restrictions have been lifted. The high prevalence of neurological diseases and rising demand for neurovascular devices for the treatment and diagnosis of diseases are expected to propel the market during the forecast period.

The growth of the studied market is also affected by the fact that the number of target patients is growing, that products are still being made and sold, and that research in the field of neurovascular therapies is increasing.

Neurovascular disorders, including arteriovenous malformations (AVMs), brain aneurysms, carotid artery disease, and intracranial atherosclerotic disease, take an enormous health and economic toll on the world population and can result in lots of neurological problems ranging from subarachnoid hemorrhage and stroke to disability and even death. An article from April 2021 said that migraines (17%), seizures (15%), neurological emergencies like meningitis and encephalitis (14%), and tumors (14%) were the most common things that people thought were a stroke.Due to the high number of neurological disorders, neurovascular devices are likely to become more useful over the next few years.

Furthermore, the strategic initiatives adopted by key players, such as research and development to develop an innovative device and rising product launches, approvals, and technological advancements in devices to meet the growing demand for neurovascular devices, are expected to drive the growth of the market. For instance, in February 2021, Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, received Breakthrough Device Designation from the United States Food and Drug Administration for its Contour Neurovascular System. The breakthrough device designation expedites the conventional development, assessment, and review processes, and such devices are marketed early. Also, in July 2021, Terumo Medical Corporation (TMC) announced the launch of the AZUR Vascular Plug. It is one of the first and only plugs compatible with a microcatheter to occlude arteries up to 8 mm in diameter. During the forecast period, the market is expected to grow because there will be so many new neurovascular devices.

Therefore, owing to factors such as the high prevalence of neurological diseases, technological advancements in products, and rising product launches, the studied market is anticipated to witness growth over the analysis period. But strict rules about neurovascular devices and a lack of skilled neurosurgeons are likely to slow the growth of the market as a whole.

Neurovascular Devices Market Trends

This section covers the major market trends shaping the Neurovascular Devices Market according to our research experts:

Ischemic Strokes is Expected to Hold Significant Market Share in the Target Disease Segment

Ischemic stroke is a heterogeneous, multifactorial disease characterized by the sudden onset of neurologic signs directly related to the places of injury in the brain where the morbid process occurs. The evaluation of multifaceted neurologic disorders, including stroke, in which a large number of genetic and epigenetic factors interact with even the environmental risk factors to increase the risk, has been revolutionized by the GWAS (genome-wide association studies) approach. Currently, magnetic resonance imaging (MRI) and computer tomography (CT) techniques are considered the gold standard for ischemic stroke detection.

According to the World Stroke Organization's 2022 report, approximately 7.6 million new ischaemic strokes occur each year.In the current year, an estimated 62% of all incident strokes worldwide are ischaemic strokes.As a result of the high incidence and prevalence of ischaemic stroke worldwide, the segment is expected to grow significantly during the forecast period, contributing to market growth.

Furthermore, the research conducted by various institutions to develop a neurovascular device used in the treatment and diagnosis of ischemic stroke is expected to propel market growth. For instance, in September 2022, researchers at the Indian Institute of Technology, Mandi, in collaboration with PGIMER Chandigarh, developed a portable and cost-effective device to detect and diagnose stroke caused by impaired blood flow to the brain. The low-cost diagnostic method can be employed in rural, underdeveloped, and isolated areas for early detection and will aid in precisely detecting ischemic stroke. The high burden of research developments is estimated to propel segment growth during the forecast period.

Neurovascular Devices Market - Incidence of Ischaemic Stroke by Gender (all Ages) (in million), Global, 2021

North America is Expected to Hold a Significant Share in the Neurovascular Devices Market Over The Forecast Period

North America is expected to have a big share of the market because there are a lot of neurovascular diseases there, the healthcare system is better, people know what technologies are out there, and there are a lot of industry players there.

According to CDC facts updated in 2022, every year more than 795,000 people in the United States have a stroke. About 610,000 of these are first or new strokes. In the United States, there is estimated to be at least one stroke every 40 seconds, and every four minutes, someone dies of a stroke. The same source also mentioned that approximately 87% of all strokes are ischemic strokes, in which blood flow to the brain gets blocked. Thus, the high prevalence of strokes in the region is estimated to propel the market for neurovascular devices during the forecast period.

Additionally, the advancements in technology and rising research and development activities leading to product launches and approvals, along with partnerships and acquisitions by key players, are helping in the market's growth. For instance, in July 2022, Rapid Medical, a developer of advanced neurovascular devices, received FDA 510(k) approval for TIGERTRIEVER for large vessel occlusions at the 2022 Society of NeuroInterventional Surgery (SNIS) annual meeting in Toronto. The device is one of the smallest revascularization devices and is designed to remove thrombi from delicate brain blood vessels during an ischemic stroke. These developments are expected to drive market growth in the region during the forecast period because they provide a less traumatic approach than existing devices.

Neurovascular Devices Market - Growth Rate by Region

Neurovascular Devices Industry Overview

The neurovascular devices market is highly competitive and consists of a few major players. The competitive landscape includes an analysis of global companies that hold significant market shares in the industry, such as Johnson & Johnson, Medtronic, Stryker, Terumo Corporation, and ASAHI INTECC CO., LTD., among others.

Neurovascular Devices Market Leaders

  1. Medtronic

  2. Johnson & Johnson

  3. Stryker

  4. Terumo Corporation

  5. ASAHI INTECC CO., LTD.

*Disclaimer: Major Players sorted in no particular order

Neurovascular Devices Market Concentration
bookmark Need More Details on Market Players and Competitors?
Download PDF

Neurovascular Devices Market News

  • September 2022: Shionogi & Co. Ltd., Shionogi Healthcare & Co. Ltd., and Pixie Dust Technologies Inc. entered into a partnership agreement to launch a business involving brain activation through sound stimulation.
  • June 2022: Medtronic launched the CE-marked fourth generation flow system, pipeline vantage with Shield technology, for endovascular treatment of brain aneurysms.

Neurovascular Devices Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Defination

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Target Patient Population

      2. 4.2.2 Ongoing Product Development and Commercialization

      3. 4.2.3 Rising Research Activities in the Field of Neurovascular Therapies

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

      2. 4.3.2 Dearth of Skilled Neurosurgeons

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Product

      1. 5.1.1 Aneurysm Coiling & Embolization Devices

      2. 5.1.2 Cerebral Balloon Angioplasty and Stenting Systems

      3. 5.1.3 Support Devices

      4. 5.1.4 Neurothrombectomy Devices

      5. 5.1.5 Other Devices (Revascularization Devices etc.)

    2. 5.2 By Target Disease

      1. 5.2.1 Ischemic Strokes

      2. 5.2.2 Cerebral Aneurysms

      3. 5.2.3 Arteriovenous Malformation and Fistulas

      4. 5.2.4 Other Target Diseases (Stenosis etc.)

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Medtronic

      2. 6.1.2 Johnson & Johnson Services, Inc.

      3. 6.1.3 ASAHI INTECC CO., LTD.

      4. 6.1.4 Penumbra, Inc.

      5. 6.1.5 Stryker

      6. 6.1.6 Terumo Corporation

      7. 6.1.7 Integer Holdings Corporation

      8. 6.1.8 MicroPort Scientific Corporation

      9. 6.1.9 Imperative Care

      10. 6.1.10 Shape Memory Medical

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
bookmark You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Neurovascular Devices Industry Segmentation

As per the scope of the report, neurovascular devices are used to treat neurological disorders. These include coils, stents, and clips that are used to treat neurovascular disorders such as brain aneurysms. These devices are widely used in the treatment and diagnosis of various types of peripheral and central nervous system disorders and ailments. The Neurovascular Devices Market is classified as follows: Product (Aneurysm Coiling and Embolization Devices, Cerebral Balloon Angioplasty and Stenting Systems, Support Devices, Neurothrombectomy Devices, and Others), Target Disease (Ischemic Strokes, Cerebral Aneurysms, Arteriovenous Malformations, and Fistalus, and Other target diseases), and Geography (North America, Europe, Asia-Pacific, Middle The market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values (in USD million) for the above segments.

By Product
Aneurysm Coiling & Embolization Devices
Cerebral Balloon Angioplasty and Stenting Systems
Support Devices
Neurothrombectomy Devices
Other Devices (Revascularization Devices etc.)
By Target Disease
Ischemic Strokes
Cerebral Aneurysms
Arteriovenous Malformation and Fistulas
Other Target Diseases (Stenosis etc.)
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
customize-icon Need A Different Region Or Segment?
Customize Now

Neurovascular Devices Market Research FAQs

The Neurovascular Devices Market is projected to register a CAGR of 7.70% during the forecast period (2024-2029)

Medtronic, Johnson & Johnson, Stryker, Terumo Corporation and ASAHI INTECC CO., LTD. are the major companies operating in the Neurovascular Devices Market.

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Neurovascular Devices Market.

The report covers the Neurovascular Devices Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Neurovascular Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Neurovascular Devices Industry Report

Statistics for the 2024 Neurovascular Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Neurovascular Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Neurovascular Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)